Table 1 Demographic, clinical and hormonal features of patients
Sample | Age/Sex | Prolactin at diagnosis (ng/mL) | Prolactin on DA (ng/mL) | Maximum diameter at diagnosis (mm) | Maximum dose of CBG (mg/week) | Categorization of response | Techniques |
|---|---|---|---|---|---|---|---|
PR-2022-002| B22-4113 | 18 F | 867 | 277 | 18 | 3 | Partial | ST, WTS, WES |
B18-6772| PRL 2018-002 | 25 F | 944 | 3152 | 22.9 | 3 | Null | ST, WTS, WES |
PR-2021-001| B21-3912-2 | 32 F | 3959 | 2263 | 25 | 4.5 | Null | ST, WTS, WES |
B18-6678-1| PRL-2018-001 | 58 F | 439 | 419 | 66 | 2 | Null | ST, WTS, WES |
B19-6520 | 22 F | 654 | 292 | 12 | 3 | Partial | ST, WES |
B18-3932 | 50 M | 1382 | 982 | 33 | 3 | Null | ST, WES |
B16-715 | 23 F | 137 | 219 | 10 | 4 | Null | ST |
B23-2486 | 76 F | 11,828 | 1972 | 39 | 3 | Partial | ST |
PR-2010-001 | 43 M | 150 | 1351 | 48 | 2 | Null | WTS, WES |
PR-2010-002 | 6 M | 150 | 12,044 | 35 | 10 | Null | WTS, WES |
PR-2022-001 | 19 F | 200 | 698.6 | 8.5 | 3.75 | Null | WTS, WES |
PR-2023-001 | 61 F | 193.4 | 441 | 44 | 3 | Null | WTS, WES |
PR-2009-001 | 25 M | 538 | 639 | 16 | 9 | Null | WTS, WES |